2 studies found for:    19704057 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment
Condition: Pancreatic Neuroendocrine Tumors in MEN1
Intervention: Drug: Somatostatin-Analog
2 Unknown 
Has Results
Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
Condition: Neuroendocrine Tumors
Interventions: Drug: Octreotide LAR (Long-acting release);   Drug: Placebo

Indicates status has not been verified in more than two years